Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma

Technology appraisal guidance
Reference number: TA306
Published: 26 February 2014

History

Lymphoma (non Hodgkin's, relapsed, refractory) - pixantrone monotherapy: Equality Impact Assessment - guidance development

Lymphoma (non Hodgkin's, relapsed, refractory) - pixantrone monotherapy: Equality Impact Assessment - guidance development (PDF 86 KB)

Published:

26 February 2014

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: final appraisal determination 2

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation 2

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation 2
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation document information
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: evaluation report information
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: evaluation report (PDF 4.08 MB)

Published:

15 October 2013

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation

Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appraisal consultation document information
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: evaluation report
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: pre-meeting briefing (PDF 552 KB)

Published:

11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Evidence Review Group report (PDF 2.91 MB)

Published:

11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Evidence Review group report - factual accuracy check (PDF 65 KB)

Published:

11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: erratum to the ERG report (PDF 138 KB)

Published:

11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Cell Therapeutics (PDF 1.74 MB)

Published:

11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: clarification
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: NICE clarification letter (PDF 113 KB)

Published:

11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Cell Therapeutics response to the NICE clarification letter (PDF 331 KB)

Published:

11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: appendix to manufacturer's clarification response (PDF 1022 KB)

Published:

11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: patient group, professional group and NHS organisation submission statements
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Lymphoma Association (PDF 44 KB)

Published:

11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: The Royal College of Physicians (PDF 45 KB)

Published:

11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: expert written personal statements
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: McMillan (PDF 27 KB)

Published:

11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Pettengell (PDF 27 KB)

Published:

11 April 2013
Non Hodgkin's lymphoma (relapsed refractory) - pixantrone monotherapy: Wilson (PDF 26 KB)

Published:

11 April 2013

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): NICE's response to consultees and commentator comments on the draft scope and provisional matrix

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): NICE's response to consultees and commentator comments on the draft scope and provisional matrix (PDF 132 KB)

Published:

04 October 2012

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final scope

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final scope (PDF 50 KB)

Published:

04 October 2012

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final matrix

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final matrix (PDF 55 KB)

Published:

04 October 2012

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final matrix (superseded)

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final matrix (superseded) (PDF 33 KB)

Published:

28 December 2011

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final scope (superseded)

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): final scope (superseded) (PDF 30 KB)

Published:

28 December 2011

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): NICE response to comments on draft scope (superseded)

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): NICE response to comments on draft scope (superseded) (PDF 97 KB)

Published:

28 December 2011

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): draft scope

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): draft scope (PDF 33 KB)

Published:

21 January 2011

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): provisional matrix

Lymphoma (non-Hodgkin's, relapsed, refactory) - pixantrone (monotherapy): provisional matrix (PDF 32 KB)

Published:

21 January 2011